Wave Life Sciences (WVE) Treasury Shares (2015 - 2026)
Wave Life Sciences' (WVE) quarterly Treasury Shares came in at $3.2 million in Q2 2026, down 18.49% YoY from $3.9 million in Q2 2025, and down 18.49% on a QoQ basis from $3.9 million in Q4 2025.
Wave Life Sciences (WVE) Treasury Shares (2015 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 12 years of Treasury Shares data on file, last reported at $3.2 million in Q2 2026.
- Quarterly Treasury Shares fell 18.49% year-over-year to $3.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.2 million (down 18.49% YoY) and the FY2025 annual result came in at $3.9 million, changed 0.0% from the prior year.
- Treasury Shares slipped to $3.2 million in Q2 2026, from $3.9 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $3.9 million in Q1 2022 to a low of $3.2 million in Q2 2026.
- A 5-year average of $3.9 million and a median of $3.9 million in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares changed 0.0% — and 2026, when it retreated 18.49%.
- Tracing WVE's Treasury Shares over 5 years: stood at $3.9 million in 2022, then changed by 0.0% to $3.9 million in 2023, then changed by 0.0% to $3.9 million in 2024, then changed by 0.0% to $3.9 million in 2025, then retreated by 18.49% to $3.2 million in 2026.
- The last three Treasury Shares figures came in at $3.2 million (Q2 2026), $3.9 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | 3.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.18 Mn |
| Jun 30, 2026 | 3.18 Mn |
| Mar 31, 2026 | 3.24 Mn |
| Mar 31, 2026 | 3.24 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 3.90 Mn |
| Dec 31, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |